Compile Data Set for Download or QSAR
Report error Found 55 Enz. Inhib. hit(s) with all data for entry = 50017585
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603097(CHEMBL5195288)
Affinity DataKd:  5nMAssay Description:Binding affinity to BRD4 BD2 (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetBromodomain-containing protein 3(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603097(CHEMBL5195288)
Affinity DataKd:  6.30nMAssay Description:Binding affinity to BRD3 BD2 (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 2(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603097(CHEMBL5195288)
Affinity DataKd:  7.90nMAssay Description:Binding affinity to BRD2 BD2 (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603088(CHEMBL5203965)
Affinity DataIC50: 20nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603097(CHEMBL5195288)
Affinity DataKd:  25nMAssay Description:Binding affinity to BRD4 BD1 (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetBromodomain-containing protein 3(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603097(CHEMBL5195288)
Affinity DataKd:  25nMAssay Description:Binding affinity to BRD3 BD1 (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain testis-specific protein(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603097(CHEMBL5195288)
Affinity DataKd:  25nMAssay Description:Binding affinity to BRDT BD2 (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain testis-specific protein(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603097(CHEMBL5195288)
Affinity DataKd:  25nMAssay Description:Binding affinity to BRDT BD1 (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 2(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603097(CHEMBL5195288)
Affinity DataKd:  40nMAssay Description:Binding affinity to BRD2 BD1 (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603097(CHEMBL5195288)
Affinity DataIC50: 63nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603089(CHEMBL5194720)
Affinity DataIC50: 79nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603091(CHEMBL5180798)
Affinity DataIC50: 79nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603096(CHEMBL5194723)
Affinity DataIC50: 79nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603092(CHEMBL5190509)
Affinity DataIC50: 100nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603096(CHEMBL5194723)
Affinity DataIC50: 100nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603097(CHEMBL5195288)
Affinity DataIC50: 126nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMedPDB3D3D Structure (crystal)
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603086(CHEMBL5176539)
Affinity DataIC50: 158nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603090(CHEMBL5189831)
Affinity DataIC50: 158nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603094(CHEMBL5172388)
Affinity DataIC50: 158nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603093(CHEMBL5186647)
Affinity DataIC50: 158nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetC-C motif chemokine 2(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603097(CHEMBL5195288)
Affinity DataIC50: 200nMAssay Description:Inhibition of MCP-1 in LPS-stimulated human whole blood incubate for 24 hrs by immuno assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603088(CHEMBL5203965)
Affinity DataIC50: 200nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603092(CHEMBL5190509)
Affinity DataIC50: 200nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetC-C motif chemokine 2(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603092(CHEMBL5190509)
Affinity DataIC50: 251nMAssay Description:Inhibition of MCP-1 in LPS-stimulated human whole blood incubate for 24 hrs by immuno assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603089(CHEMBL5194720)
Affinity DataIC50: 251nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603083(CHEMBL5171846)
Affinity DataIC50: 316nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603091(CHEMBL5180798)
Affinity DataIC50: 316nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603080(CHEMBL5174030)
Affinity DataIC50: 316nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetC-C motif chemokine 2(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603089(CHEMBL5194720)
Affinity DataIC50: 398nMAssay Description:Inhibition of MCP-1 in LPS-stimulated human whole blood incubate for 24 hrs by immuno assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603086(CHEMBL5176539)
Affinity DataIC50: 501nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603087(CHEMBL5188027)
Affinity DataIC50: 501nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603087(CHEMBL5188027)
Affinity DataIC50: 501nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603095(CHEMBL5205820)
Affinity DataIC50: 501nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603082(CHEMBL5208076)
Affinity DataIC50: 501nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603085(CHEMBL5187775)
Affinity DataIC50: 631nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603090(CHEMBL5189831)
Affinity DataIC50: 794nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603094(CHEMBL5172388)
Affinity DataIC50: 794nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603093(CHEMBL5186647)
Affinity DataIC50: 794nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603083(CHEMBL5171846)
Affinity DataIC50: 794nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603084(CHEMBL5192618)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603080(CHEMBL5174030)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603082(CHEMBL5208076)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603095(CHEMBL5205820)
Affinity DataIC50: 1.00E+3nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603085(CHEMBL5187775)
Affinity DataIC50: 1.26E+3nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603081(CHEMBL5170570)
Affinity DataIC50: 1.26E+3nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603084(CHEMBL5192618)
Affinity DataIC50: 1.26E+3nMAssay Description:Inhibition of BRD4 BD1 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetBromodomain-containing protein 4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603081(CHEMBL5170570)
Affinity DataIC50: 1.26E+3nMAssay Description:Inhibition of BRD4 BD2 (unknown origin) incubated for 30 mins in presence of fluorescent ligand by TR-FRET methodMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetHistone acetyltransferase p300(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603097(CHEMBL5195288)
Affinity DataKd:  2.51E+3nMAssay Description:Binding affinity to EP300 (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetCREB-binding protein(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603097(CHEMBL5195288)
Affinity DataKd:  2.51E+3nMAssay Description:Binding affinity to CREBBP (unknown origin) assessed as dissociation constantMore data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
TargetCytochrome P450 3A4(Human)
Glaxosmithkline R&D

Curated by ChEMBL
LigandPNGBDBM50603089(CHEMBL5194720)
Affinity DataIC50: 3.98E+4nMAssay Description:Inhibition of CYP3A4 (unknown origin)More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/24/2023
Entry Details
PubMed
Displayed 1 to 50 (of 55 total ) | Next | Last >>
Jump to: